Does your institution allow Ciprodex to be allowed in trachostomy tubes? I've seen literature to support its use in preventing granulation tissue formation.

However, there has been some concerns brought up about the boric acid content of Ciprodex.

Has anyone had any discussions surrounding this?

Greetings,

A question has come up at our Radiology Clinic regarding patient's ability to drive home after receiving diphenhydramine for an allergic reaction. Does anyone have an institutional policy or standard of practice on this (e.g. patients are advised not drive for X hrs, or patients are not allowed to drive themselves, etc.)?

Thank you,
Daniel

We are in the process of rewriting the charter for our Medication Safety Committee. Does anyone have a charter for their organization that they are willing to share?

Thank you!
Vaishali

Interested in learning about safeguards that facilities stocking the phytonadione
1 mg ampule product have put in place.

General concerns we have identified at this point include:
1. mix-ups with phytonadion 10 mg ampule
2. mix-ups with methylergonovine ampule

Appreciate any insight to safeguards or risks you may have. TIA!

I am part of a 500+ bed, urban, academic organization. As far as antibiotic infusions go, we currently only run Zosyn as a primary infusion (run over 4 hours); our other antibiotic infusions are run as a primary/secondary set up. During the normal saline shortage, we ran all antibiotics primary and flushed with a 10 mL flush post infusion. Now that we are able to go back to our primary/secondary set up, we are getting some pushback from nursing.

How does your organization infuse IV antibiotics?

How do you draw up a patient-specific dose of an inhaled med? It is my understanding that the product needs to remain sterile, therefore doses should be drawn up in an ISO Class 5 environment into a sterile syringe.

1. Are you drawing up inhaled meds in your IV room hood?

2. Do you dispense them in an IV syringe, or an oral syringe?

3. If you do use oral syringes, are you using a STERILE oral syringe? If so, what manufacturer are you using? (Looking for sizes up to 10mL)

thank you for taking time to respond!

The package insert Westward brand injectable morphine specifically states 'for intravenous use' / for 'direct IV injection' - there is no reference to IM or subcutaneous routes.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202515s000lbl.pdf
I'm soliciting feedback and rationale on whether the IM or Subcutaneous routes could be included in an EMR build (or not).

Curious to see what type of MRI compatible infusion pumps other hospitals are currently using? We are using IRadimed pumps at our facility.

Thank-you in advance for all who comments, much appreciated.

Natalie Zilban
Medication Safety Officer
Memorial Healthcare System
Hollywood, FL

We are standardizing our RCA process across our health system. Initially we are requiring all sites complete an RCA for SREs (at a minimum). Eventually I'd love to expand this of course.

As you are probably aware the SRE definition for medication-related events is pretty generic. It is difficult to define "serious injury". Also, I would like to include events where a lack of monitoring led to serious injury, even though it is not technically covered by the examples given.

Has anyone developed or implemented a way to make the age of a medication on the history (when it was last entered or updated) visible to clinicians (MDs, RPhs, RNs, NPs, PAs, CPhTs)?

If so, has anyone incorporated alerting to the prescriber on reconciliation based on the age of the history being reconciled?

Since we are an EPIC shop, any insight or experience with a "Med Rec Module" for EPIC would also be most appreciated.

Regards,

Michael Van Ornum